Arch Development Corp. v. Osi Pharmaceuticals, LLC ( 2019 )

NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ ARCH DEVELOPMENT CORPORATION, DANA- FARBER CANCER INSTITUTE, INC., Appellants v. OSI PHARMACEUTICALS, LLC, GENENTECH, INC., Appellees UNITED STATES, Intervenor ______________________ 2018-1485 ______________________ Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2016- 01034. ______________________ JUDGMENT ______________________ PETER A. SULLIVAN, Foley Hoag LLP, New York, NY, argued for appellants. Also represented by STEPHEN KENNY; DEANN FORAN SMITH, Boston, MA. BRIAN ROBERT MATSUI, Morrison & Foerster LLP, Washington, DC, argued for all appellees. Appellee Genen- tech, Inc. also represented by SETH W. LLOYD; MATTHEW A. CHIVVIS, MATTHEW IAN KREEGER, San Francisco, CA. THOMAS SAUNDERS, Wilmer Cutler Pickering Hale and Dorr LLP, Washington, DC, for appellee OSI Pharmaceu- ticals, LLC. Also represented by DAVID LANGDON CAVANAUGH, AMANDA L. MAJOR, HEATHER M. PETRUZZI, AMY K. WIGMORE; TIMOTHY ANDREW COOK, EMILY R. WHELAN, Boston, MA. KATHERINE TWOMEY ALLEN, Appellate Staff, Civil Divi- sion, United States Department of Justice, Washington, DC, argued for intervenor. Also represented by MARK R. FREEMAN, SCOTT R. MCINTOSH, JOSEPH H. HUNT; THOMAS W. KRAUSE, JOSEPH MATAL, FARHEENA YASMEEN RASHEED, Office of the Solicitor, United States Patent and Trade- mark Office, Alexandria, VA. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (PROST, Chief Judge, LOURIE and BRYSON, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36. ENTERED BY ORDER OF THE COURT May 9, 2019 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court